InvestorsHub Logo
Followers 1
Posts 114
Boards Moderated 0
Alias Born 12/26/2017

Re: Phantom Lord post# 28663

Thursday, 10/10/2019 11:24:15 AM

Thursday, October 10, 2019 11:24:15 AM

Post# of 34625
I posted this before Phantom Lord, but if I was PH, I would approach Celgene about a Darzalex/Multi-TAA trial in MM. Minimal risk, maximal response duration. Thoughts?
https://www.cancertherapyadvisor.com/home/cancer-topics/multiple-myeloma/multiple-myeloma-isatuximab-immunse-response-correlates-clinical-response/2/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News